189 related articles for article (PubMed ID: 9203663)
1. Phospholipase activity in Cryptococcus neoformans: a new virulence factor?
Chen SC; Muller M; Zhou JZ; Wright LC; Sorrell TC
J Infect Dis; 1997 Feb; 175(2):414-20. PubMed ID: 9203663
[TBL] [Abstract][Full Text] [Related]
2. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans.
Chen SC; Wright LC; Santangelo RT; Muller M; Moran VR; Kuchel PW; Sorrell TC
Infect Immun; 1997 Feb; 65(2):405-11. PubMed ID: 9009289
[TBL] [Abstract][Full Text] [Related]
3. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.
Cox GM; McDade HC; Chen SC; Tucker SC; Gottfredsson M; Wright LC; Sorrell TC; Leidich SD; Casadevall A; Ghannoum MA; Perfect JR
Mol Microbiol; 2001 Jan; 39(1):166-75. PubMed ID: 11123698
[TBL] [Abstract][Full Text] [Related]
4. Strain-dependent effects of environmental signals on the production of extracellular phospholipase by Cryptococcus neoformans.
Wright LC; Chen SC; Wilson CF; Simpanya MF; Blackstock R; Cox GM; Murphy JW; Sorrell TC
FEMS Microbiol Lett; 2002 Apr; 209(2):175-81. PubMed ID: 12007802
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase activity in Cryptococcus neoformans.
Vidotto V; Sinicco A; Di Fraia D; Cardaropoli S; Aoki S; Ito-Kuwa S
Mycopathologia; 1996-1997; 136(3):119-23. PubMed ID: 9276940
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans.
Chen SC; Wright LC; Golding JC; Sorrell TC
Biochem J; 2000 Apr; 347(Pt 2):431-9. PubMed ID: 10749672
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic characterization of clinical and environmental Cryptococcus neoformans strains isolated in Italy.
Pini G; Faggi E; Campisi E
Rev Iberoam Micol; 2017; 34(2):77-82. PubMed ID: 28215482
[TBL] [Abstract][Full Text] [Related]
8. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.
Santangelo R; Zoellner H; Sorrell T; Wilson C; Donald C; Djordjevic J; Shounan Y; Wright L
Infect Immun; 2004 Apr; 72(4):2229-39. PubMed ID: 15039347
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state.
Santangelo RT; Nouri-Sorkhabi MH; Sorrell TC; Cagney M; Chen SCA; Kuchel PW; Wright LC
J Med Microbiol; 1999 Aug; 48(8):731-740. PubMed ID: 10450996
[TBL] [Abstract][Full Text] [Related]
10. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes.
Cordeiro Rde A; Nogueira GC; Brilhante RS; Teixeira CE; Mourão CI; Castelo-Branco Dde S; Paiva Mde A; Ribeiro JF; Monteiro AJ; Sidrim JJ; Rocha MF
Vet Microbiol; 2012 Oct; 159(3-4):375-80. PubMed ID: 22580194
[TBL] [Abstract][Full Text] [Related]
11. Role of conserved active site residues in catalysis by phospholipase B1 from Cryptococcus neoformans.
Jones PM; Turner KM; Djordjevic JT; Sorrell TC; Wright LC; George AM
Biochemistry; 2007 Sep; 46(35):10024-32. PubMed ID: 17685590
[TBL] [Abstract][Full Text] [Related]
12. In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.
Ganendren R; Widmer F; Singhal V; Wilson C; Sorrell T; Wright L
Antimicrob Agents Chemother; 2004 May; 48(5):1561-9. PubMed ID: 15105106
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcal phospholipases: a novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii.
Wright LC; Payne J; Santangelo RT; Simpanya MF; Chen SC; Widmer F; Sorrell TC
Biochem J; 2004 Dec; 384(Pt 2):377-84. PubMed ID: 15320865
[TBL] [Abstract][Full Text] [Related]
14. Comparison of phospholipase production in Cryptococcus neoformans isolates from AIDS patients and bird droppings.
Vidotto V; Leone R; Sinicco A; Ito-kuwa S; Criseo G
Mycopathologia; 1998; 142(2):71-6. PubMed ID: 9926419
[TBL] [Abstract][Full Text] [Related]
15. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains.
Irokanulo EA; Akueshi CO
J Med Microbiol; 1995 Oct; 43(4):289-93. PubMed ID: 7562991
[TBL] [Abstract][Full Text] [Related]
16. Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.
Widmer F; Wright LC; Obando D; Handke R; Ganendren R; Ellis DH; Sorrell TC
Antimicrob Agents Chemother; 2006 Feb; 50(2):414-21. PubMed ID: 16436691
[TBL] [Abstract][Full Text] [Related]
17. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
18. Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB/c mice and correlation with exoenzyme activity.
da Silva EG; Baroni FA; Viani FC; Ruiz LDS; Gandra RF; Auler ME; Dias ALT; Gambale W; Paula CR
J Med Microbiol; 2006 Feb; 55(Pt 2):139-142. PubMed ID: 16434704
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcal phospholipase B antigen is not detected in serum of patients infected with Cryptococcus neoformans using a sandwich enzyme-linked immunosorbent assay.
Wu QX; Chen SC; Santangelo RT; Martin P; Malik R; Sorrell TC
FEMS Yeast Res; 2007 May; 7(3):465-70. PubMed ID: 17266733
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors.
Clancy CJ; Nguyen MH; Alandoerffer R; Cheng S; Iczkowski K; Richardson M; Graybill JR
Microbiology (Reading); 2006 Aug; 152(Pt 8):2247-2255. PubMed ID: 16849791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
